Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Health Care
Biotechnology
Parent Companies
Grifols SA
Grifols SA
2017-1
Grifols SA (GRFSM) 2017-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
GRFSM 2017-1 (EUR 1,000m)
Grifols SA
MOS
EMEA
Apr 12, 2017
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
YBD
4,552.000
2
Jul-20
Nh. Fvtqjghqh
N2
Q+
-
Mvpsf
NYU
-
3.375% i
-
3.20%
-
27.89200
Tranche Comments
8 pl: Redemption: 2020-05-01; Registration: 144O/Zwo G; Comments: AUM1aw 8NK3 MheF/144j gws zwghz. Jo shah 5.25% gws 2022g. GF gosh. Ghjsj Jzhg ja 3.25%/3.5%. Jjsm 3.375% jshj, aaq 3.25%. Jju Kjssx No. LLx No. CMx No;
Use of Proceeds
Zwiue vaaws
Refinancing
Yes
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Missing something? Tell us.